Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
06:00:00 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 12.20 USD | -3.94% |
|
-6.30% | +100.66% |
| Market Cap | 549M 735M 641M 605M 1.03B 70.48B 1.03B 7.24B 2.8B 35.84B 2.76B 2.7B 115B | P/E 2026 * |
-22.9x | P/E 2027 * | -18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 416M 557M 485M 458M 780M 53.4B 783M 5.49B 2.12B 27.15B 2.09B 2.04B 87.36B | EV / Sales 2026 * |
1,291x | EV / Sales 2027 * | 500x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SLN | Delayed | |
CBOE
| SLN | Real-time | |
|
Tradegate
| XRP2 | Real-time | |
|
Deutsche Boerse AG
| XRP2 | Delayed | |
|
Börse Stuttgart
| XRP2 | Delayed | |
|
Boerse Muenchen
| XRP2 | Real-time |
Last Transcript: Silence Therapeutics plc
| 1 day | -3.94% | ||
| 1 week | -6.30% | ||
| Current month | -9.83% | ||
| 1 month | -13.48% | ||
| 3 months | +76.05% | ||
| 6 months | +84.01% | ||
| Current year | +100.66% |
| 1 week | 12.1 |  | 13.28 |
| 1 month | 12.1 | | 15.28 |
| Current year | 4.19 | | 17.58 |
| 1 year | 4.19 | | 17.58 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/7/26 | Sell | 865,112 | 0.6105% | |||
| 2/1/26 | Free | Chief Financial Officer | 375,000 | 0.2646% | ||
| 2/1/26 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.94% | -6.30% | +142.54% | +25.39% | 735M | |
| +0.11% | +2.71% | +0.33% | +28.59% | 46.28B | |
| -1.12% | +1.78% | +40.07% | +27.26% | 43.85B | |
| -3.04% | -6.29% | +322.27% | +517.36% | 40.93B | |
| -0.74% | +1.25% | +2.32% | +67.94% | 39.9B | |
| -0.50% | +0.67% | +11.79% | +40.51% | 29.5B | |
| -0.46% | +4.22% | +21.99% | +124.21% | 17.09B | |
| -0.97% | -10.17% | - | - | 15.55B | |
| -0.57% | +8.12% | +22.15% | +38.93% | 15.22B | |
| -3.14% | +31.91% | -10.60% | - | 14.05B | |
| Average | -1.29% | +2.76% | +61.43% | +108.77% | 26.31B | |
| Weighted average by Cap. | -1.03% | +1.85% | +64.92% | +129.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 322K 431K 376K 355K 604K 41.38M 607K 4.25M 1.64M 21.04M 1.62M 1.58M 67.69M | 751K 1M 875K 827K 1.41M 96.32M 1.41M 9.9M 3.82M 48.97M 3.77M 3.69M 158M |
| Net income | -42.14M -56.36M -49.14M -46.4M -78.95M -5.41B -79.27M -556M -214M -2.75B -212M -207M -8.85B | -71.01M -94.97M -82.82M -78.2M -133M -9.11B -134M -937M -361M -4.63B -357M -349M -14.91B |
| Net Debt | -133M -178M -155M -147M -249M -17.08B -250M -1.76B -678M -8.68B -669M -654M -27.94B | -174M -233M -203M -192M -326M -22.34B -327M -2.3B -886M -11.36B -874M -855M -36.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | USD 12.20 | -3.94% | 1,142,412 |
| 17/09/26 | USD 12.70 | +1.60% | 690,466 |
| 16/09/26 | USD 12.50 | +0.32% | 983,806 |
| 15/09/26 | USD 12.46 | -4.59% | 1,383,436 |
| 14/09/26 | USD 13.06 | +0.31% | 1,095,255 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
